Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tailored platelet inhibition strategy after elective PCI
2010-018435-18Phase 4Terminated
- Sponsor
- Papworth Hospital NHS Foundation Trust
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of clopidogrel and prasugrel in coronary arteriosclerosis (2 arms), sponsored by Papworth Hospital NHS Foundation Trust. Primary endpoint: Difference in mean platelet inhibition at day 28 between standard and tailored protocols. Started Mar 2010; status: terminated.
02
Drugs
clopidogrelprasugrel
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2010-018435-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018435-18.